Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release.
Level 5 - mechanism / opinion, no new human data
Preclinical laboratory cellular and animal model study
PubMed 28874589 · doi:10.1073/pnas.1705768114
What was done
Investigated the subcellular localization of the melatonin type 1 (MT1) receptor, its associated G protein, and β-arrestins in neuronal mitochondria using in vitro assays. Evaluated the site of melatonin synthesis, tested the effect of mitochondrial MT1 pathway activation on stress-mediated cytochrome c release and caspase activation, and assessed the effects of mitochondrial MT1 overexpression in a mouse model of ischemic brain injury.
What was found
Melatonin was synthesized in the mitochondrial matrix and released to activate mitochondrial MT1 signaling, which inhibited stress-induced cytochrome c release and caspase activation. In mice, overexpression of mitochondrial MT1 reduced ischemic brain injury. The abstract reports directional findings without numerical values or sample sizes.
Why it matters
Discovers an organelle-level "automitocrine" GPCR signaling pathway, demonstrating that mitochondria autonomously synthesize melatonin to regulate their own survival pathways and protect against ischemic injury.
Limits
Findings are limited to bench and rodent models with unestablished clinical translation in humans. The abstract does not disclose sample sizes, specific quantitative effect sizes, or experimental error margins.
Cited by
- supports Melatonin is synthesized directly inside human mitochondria.